The association between body mass index and abdominal obesity with hypertension among South Asian population: findings from nationally representative surveys

키워드

참고문헌 (53)

1. Liu L, "National, regional, and global causes of mortality in 5–19-year-olds from 2000 to 2019 : a systematic analysis", Lancet Glob Health, 10, pp.e337~e347 (2022)[DOI]
2. Ostchega Y, "Abdominal obesity, body mass index, and hypertension in US adults : NHANES 2007–2010", Am J Hypertens, 25, pp.1271~1278 (2012)[DOI]
3. Klein S, "Waist Circumference and Cardiometabolic Risk : a Consensus Statement from Shaping America’s Health : Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association", Obesity(Silver Spring), 15, pp.1061~1067 (2007)[DOI]
4. Grundy SM, "Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines", Arterioscler Thromb Vasc Biol, 24 (2004)[DOI]
5. Casanueva FF, "Relationship of abdominal obesity with cardiovascular disease, diabetes and hyperlipidaemia in Spain", Clin Endocrinol(Oxf), 73, pp.35~40 (2010)[DOI]
6. Van Gaal LF, "Mechanisms linking obesity with cardiovascular disease", Nature, 444, pp.875~880 (2006)[DOI]
7. Kotchen TA, "Obesity-related hypertension : epidemiology, pathophysiology, and clinical management", Am J Hypertens, 23, pp.1170~1178 (2010)[DOI]
8. Abbafati C, "Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019 : a systematic analysis for the Global Burden of Disease Study 2019", Lancet, 396, pp.1204~1222 (2020)[DOI]
9. Jayawardena R, "Abdominal obesity and metabolic syndrome in South Asians : prevention and management", Expert Rev Endocrinol Metab, 16, pp.339~349 (2021)[DOI]
10. Misra A, "Obesity and dyslipidemia in South Asians", Nutrients, 5, pp.2708~2733 (2013)[DOI]
11. Misra A, "The metabolic syndrome in South Asians : Epidemiology, determinants, and prevention", Metab Syndr Relat Disord, 7, pp.497~514 (2009)[DOI]
12. Misra A, "Obesity and the metabolic syndrome in developing countries : Focus on South Asians", Nestle Nutr Inst Workshop Ser, 78, pp.133~140 (2014)[DOI]
13. Misra A, "Body fat, metabolic syndrome and hyperglycemia in South Asians", J Diabetes Complications, 32, pp.1068~1075 (2018)[DOI]
14. Ramachandran A, "Obesity in Asia – is it different from rest of the world", Diabetes Metab Res Rev, 28, pp.47~51 (2012)[DOI]
15. Gupta R Das, "Prevalence and associated factors of abdominal obesity in the South Asian population : findings from nationally representative surveys", J Public Health(Bangkok) (2023)[DOI]
16. Gupta R Das, "Obesity and Abdominal Obesity in Indian Population : Findings from a Nationally Representative Study of 698, 286 Participants", Epidemiologia, 4, pp.163~172 (2023)
17. Bhupathiraju SN, "Epidemiology of Obesity and Diabetes and Their Cardiovascular Complications", Circ Res, 118, pp.1723~1735 (2016)[DOI]
18. Joshi SR, "Prevalence of dyslipidemia in urban and rural India : the ICMR-INDIAB study", PLoS One, 9 (2014)[DOI]
19. "Non-Communicable Disease Risk Factors: Bhutan STEPS Survey 2019. Thimphu" (2020)[URL]
20. "Report of Non Communicable Disease Risk Factors: STEPS Survey Nepal 2019" (2020)[URL]
21. "Non Communicable Disease Risk Factor Survey Sri Lanka 2015" (2015)[URL]
22. "Country Office for Bangladesh. National STEPS survey for non-communicable diseases risk factors in Bangladesh 2018" (2018)[URL]
23. "Country Office for Afghanistan. National Non-Communicable Disease Risk Factors Survey" (2018)[URL]
24. Chobanian AV, "The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure : the JNC 7 report", JAMA, 289, pp.2560~2572 (2003)[DOI]
25. Alberti KGMM, "The metabolic syndrome—a new worldwide definition", Lancet, 366, pp.1059~1062 (2005)
26. "Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies", Lancet, 363, pp.157~163 (2004)[DOI]
27. Gupta R Das, "Prevalence and Associated Factors with Ideal Cardiovascular Health Metrics in Bangladesh : Analysis of the Nationally Representative STEPS 2018 Survey", Epidemiologia, 3, pp.533~543 (2022)
28. Gupta R Das, "Prevalence and associated factors of metabolic syndrome among Bangladeshi adults : evidence from a nation-wide survey", Diabetes Epidemiology and Management, 5, pp.100037~ (2022)
29. "Global recommendations on physical activity for health" (2010)[URL]
30. Misra A, "Waist circumference cutoff points and action levels for Asian Indians for identification of abdominal obesity", Int J Obes, 30, pp.106~111 (2006)
31. Zhou W, "Body mass index, abdominal fatness, and hypertension incidence : a doseresponse meta-analysis of prospective studies", J Hum Hypertens, 32, pp.321~333 (2018)
32. Jayedi A, "Body mass index, abdominal adiposity, weight gain and risk of developing hypertension: a systematic review and dose–response meta‐analysis of more than 2.3 million participants", Obes Rev, 19, pp.654~667 (2018)
33. Peixoto M do RG, "Waist circumference and body mass index as predictors of hypertension", Arq Bras Cardiol, 87, pp.462~470 (2006)
34. Ren H, "Association of normal-weight central obesity with hypertension : a cross-sectional study from the China health and nutrition survey", BMC Cardiovasc Disord, 23, pp.1~11 (2023)
35. Ross R, "Waist circumference as a vital sign in clinical practice : a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity", Nat Rev Endocrinol, 16, pp.177~189 (2020)
36. Dorresteijn JAN, "Mechanisms linking obesity to hypertension", Obes Rev, 13, pp.17~26 (2012)
37. Kang YS, "Obesity associated hypertension : new insights into mechanism", Electrolyte Blood Press, 11, pp.46~ (2013)
38. Yajnik CS, "The YY paradox", Lancet, 363, pp.163~ (2004)
39. Sharma S, "Hypertension and cardiovascular disease in South Asia : No end in sight", J Am Soc Hypertens, 2, pp.125~130 (2008)
40. Lambert EA, "Obesity-Associated organ damage and sympathetic nervous activity : a target for treatment?", Hypertension, 73, pp.1150~1159 (2019)
41. Wofford MR, "Antihypertensive effect of α-and β-adrenergic blockade in obese and lean hypertensive subjects", Am J Hypertens, 14, pp.694~698 (2001)
42. Bentley-Lewis R, "Body mass index predicts aldosterone production in normotensive adults on a high-salt diet", J Clin Endocrinol Metab, 92, pp.4472~4475 (2007)
43. Engeli S, "The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension", J Mol Med, 79, pp.21~29 (2001)
44. Dwyer TM, "Distribution of renal medullary hyaluronan in lean and obese rabbits", Kidney Int, 58, pp.721~729 (2000)
45. Healy V, "The adrenergic regulation of proximal tubular Na+", H+ exchanger 3 in the rat, 2014, pp.210, 678~689
46. Kotsis V, "Mechanisms of obesity-induced hypertension", Hypertens Res, 33, pp.386~393 (2010)
47. Kambham N, "Obesity-related glomerulopathy : an emerging epidemic", Kidney Int, 59, pp.1498~1509 (2001)
48. Considine RV, "Serum immunoreactive-leptin concentrations in normal-weight and obese humans", N Engl J Med, 334, pp.292~295 (1996)
49. Gudbjörnsdottir S, "Insulin increases forearm vascular resistance in obese, insulin-resistant hypertensives", J Hypertens, 14, pp.91~98 (1996)
50. Anderson EA, "Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans", Hypertension, 19, pp.621~627 (1992)
51. "Scale-up efforts to prevent, detect and control hypertension: WHO"[URL]
52. Zhou B, "Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension", Nat Rev Cardiol, 18, pp.785~802 (2021)
53. "Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants", Lancet, 398, pp.957~980 (2021)[DOI]

관련 논문AI추천